[Pharmacological treatment of obesity. Drugs with predominantly anorectic action].
D000662:Amphetamines / Q000009:adverse effects / Q000627:therapeutic use; D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D005277:Fenfluramine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy*
D000662:Amphetamines; D001067:Appetite Depressants; D005473:Fluoxetine; D005277:Fenfluramine; D009270:Naloxone; C001584:benfluorex
Terapia farmacologica dell'obesità. Farmaci ad azione prevalentemente anoressante.